openPR Logo
Press release

Surge In Livestock Population Drives Growth In The Foot And Mouth Disease Vaccine Market: Key Factor Driving The Growth In The Foot And Mouth Disease Vaccine Market

04-15-2025 09:49 AM CET | Health & Medicine

Press release from: The Business Research Company

Foot And Mouth Disease Vaccine

Foot And Mouth Disease Vaccine

The Foot And Mouth Disease Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Foot And Mouth Disease Vaccine Market Size During the Forecast Period?
Over the past few years, the market size for the foot and mouth disease vaccine has seen robust growth. It is projected to expand from $2.61 billion in 2024 to a sizable $2.84 billion in 2025, at a compound annual growth rate (CAGR) of 8.9%. The historical growth is linked to the emergence of multivalent vaccines, instances of foot and mouth disease, government-led initiatives to control the disease, emphasis on food safety, economic repercussions of FMD flare-ups, and funds funneled into research and development.

The market for foot and mouth disease vaccine is predicted to witness a substantial increase in size over the coming years. The expected growth rate is 10.1% compound annual growth rate (CAGR) reaching a total value of $4.17 billion by 2029. Factors contributing to this growth in the forecast period include the effects of climate change on the spread of disease, the emergence of new FMD strains, one health approach, the digital transformation of vaccine distribution, improved cold chain infrastructure for vaccines, ongoing enhancements in vaccine safety, and the integration with precision livestock farming and international aid for vaccination programs. The forecast period also sees key trends including global initiatives to eradicate FMD, the development of multivalent vaccines, collaborations between public and private entities, advancements in diagnostic and surveillance technologies, innovations in biotechnology, genomic surveillance and the use of marker vaccines.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8522

What Are the High-Growth Segments in the Foot And Mouth Disease Vaccine Market?
The foot and mouth disease vaccine market covered in this report is segmented -

1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines
2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals
3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels

Subsegments:
1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines
2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines
3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines
4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8522&type=smp

What Key Drivers Are Expected to Influence Future Foot And Mouth Disease Vaccine Market Growth?
The escalating number of farm animals is triggering the expansion of the foot and mouth disease vaccine market. These animals, such as cows, horses, and pigs, are raised, sheltered, and used by people. The increasing demand for livestock products is leading to a surge in the livestock population. With the rise in livestock, the possibility of foot and mouth disease also increases, paving the way for growth in the vaccine market. As evidence of this, a 2022 report from the US Department of Agriculture stated that India's national cattle herd rose from 1.2 million in 2021 to 306.7 million in 2022. Hence, the expanding livestock population will fuel the growth of the foot and mouth disease vaccine market.

Which Companies Hold the Largest Share Across Different Foot And Mouth Disease Vaccine Market Segments?
Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., Brilliant Bio Pharma Ltd., Intervet India Private Limited, Biovet Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, VECOL S.A, VETAL Animal Health Products Inc., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Dong Bang Co. Ltd., FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, MEVAC, Agrovet Market S.A., Alivira Animal Health Limited, Southern Cross Group, SPIC Gene Science Technology Development Co. Ltd., Zoetis Inc.

What Trends Are Driving Growth in The Foot And Mouth Disease Vaccine Market?
A key trend in the foot-and-mouth disease vaccine market is the phenomenon of strategic alliances. The principal companies in the market are partnering up to exploit each other's assets and pave the pathway into fresh markets. For instance, Biogénesis Bagó, an Argentinian biotech firm highly skilled in foot-and-mouth disease vaccines, cemented an alliance with FVC in July 2022 to establish a sophisticated FMD vaccine facility in South Korea. This strategic alliance will allow South Korea to have access to state-of-the-art technologies, empower the country to provide its domestic market with secure, superior FMD vaccines, design more cost-effective solutions for local livestock farmers, and preserve the country's sanitary status. FVC is renowned for providing information technology services and is based in South Korea.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/foot-and-mouth-disease-vaccine-global-market-report

What Are the Emerging Geographies for The Foot And Mouth Disease Vaccine Market Growth?
Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2024. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Foot And Mouth Disease Vaccine Market?
2. What is the CAGR expected in the Foot And Mouth Disease Vaccine Market?
3. What Are the Key Innovations Transforming the Foot And Mouth Disease Vaccine Industry?
4. Which Region Is Leading the Foot And Mouth Disease Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surge In Livestock Population Drives Growth In The Foot And Mouth Disease Vaccine Market: Key Factor Driving The Growth In The Foot And Mouth Disease Vaccine Market here

News-ID: 3971213 • Views:

More Releases from The Business Research Company

Analysis of Key Market Segments Driving the UV-C LED Market
Analysis of Key Market Segments Driving the UV-C LED Market
The UV-C LED market is on the cusp of remarkable expansion, driven by growing demands for efficient sterilization and technological innovation. As industries and consumers increasingly prioritize chemical-free sanitation methods, the adoption of UV-C LED technology is set to transform disinfection practices in both residential and commercial sectors. Let's delve into the market's expected growth, key players, influencing trends, and segmentation details. Projected Expansion and Market Size of the UV-C LED
Emerging Growth Trends Driving Expansion in the Underwater Connector Market
Emerging Growth Trends Driving Expansion in the Underwater Connector Market
The underwater connector market is gaining significant attention as subsea technologies advance, particularly with increasing offshore activities and underwater exploration. This sector is expected to experience strong growth driven by several technological and industry developments. Let's explore the market size, key players, emerging trends, and segmentation to understand its trajectory through 2030. Growth Outlook for the Underwater Connector Market by 2030 The underwater connector market is anticipated to expand significantly, reaching
Analysis of Key Market Segments Driving the Ultra-High-Luminance Head-Up Display (HUD) Market
Analysis of Key Market Segments Driving the Ultra-High-Luminance Head-Up Display …
The ultra-high-luminance head-up display (HUD) market is set to experience significant expansion over the coming years, driven by rapid advancements in automotive and aviation technologies. This evolving market promises notable growth, fueled by increasing adoption of augmented reality HUDs and cutting-edge display innovations. Projected Growth and Market Value of the Ultra-High-Luminance Head-Up Display Market The ultra-high-luminance head-up display market is anticipated to reach a valuation of $3.07 billion by 2030. This
Emerging Growth Patterns Driving Expansion in the Tunable Filter Market
Emerging Growth Patterns Driving Expansion in the Tunable Filter Market
The tunable filter market is on the verge of significant expansion, driven by technological advancements and increasing demand across various sectors. As industries continue to innovate, tunable filters are becoming essential components in modern communication, sensing, and imaging systems. Here is a detailed look at the market's size, key players, trends, and segment analysis shaping its future. Projected Growth Trajectory and Market Size of the Tunable Filter Market The tunable filter

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion